Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2005; 11(20): 3118-3121
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3118
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3118
Patients with granuloma Group I | Patients without granuloma Group II | Significance | |
Number of patients | 25 | 31 | NS |
Female/male ratio (No.) | 15/10 | 16/15 | NS |
Median age (yr) | 29.60±11.32 | 36.46±12.94 | NS |
Localization | |||
Small bowel only | 1 (4%) | 4 (12.9%) | NS |
Large bowel only | 10 (40%) | 8 (25.8%) | NS |
Small and large bowel | 10 (40%) | 17 (54.8%) | NS |
UGT involvement | 4 (16%) | 2 (6.4%) | P<0.05 |
Disease behavior type | |||
Inflammatory | 8 (32%) | 15 (48.4%) | NS |
Stricturing | 6 (24%) | 9 (29.0%) | NS |
Penetrating | 11 (44%) | 7 (22.6%) | NS |
Activity of CD | |||
CDAI | 218.9±108.2 | 144.1±92.5 | P = 0.01 |
Endoscopic scores | 6.60±3.53 | 5.35±4.20 | NS |
- Citation: Molnár T, Tiszlavicz L, Gyulai C, Nagy F, Lonovics J. Clinical significance of granuloma in Crohn’s disease. World J Gastroenterol 2005; 11(20): 3118-3121
- URL: https://www.wjgnet.com/1007-9327/full/v11/i20/3118.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i20.3118